Condition
Ovarian Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Ovarian Diseases clinical trials that are recruiting, at sites in 2 countries (most in Israel (1), China (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Combining adebrelimab and fuzuloparib for treating recurrent platinum-resistant ovarian cancer
This study is testing a new combination treatment of adebrelimab and fuzuloparib to see if it helps people with recurrent platinum-resistant ovarian cancer who haven't had other systemic treatments.
-
Combination of Pembrolizumab and Lenvatinib for Ovarian Cancer
This study is testing a combination of two medications, pembrolizumab and lenvatinib, to see if they can help women with recurrent ovarian cancer that is sensitive to platinum-based treatments.
Related topics
Quick answers
How many Ovarian Diseases clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Israel (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.